Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 10:08 am Sale |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW Investments, LP | 0 0.000% |
-2,353,015 (Position Closed) |
Filing History |
| 2023-02-13 6:14 pm Sale |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 1,810,835 5.100% |
-118,366 (-6.14%) |
Filing History |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | iTeos Therapeutics, Inc. ITOS |
The Vanguard Group | 1,819,030 5.110% |
1,819,030 (New Position) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
4,479,421 12.600% |
0 (Unchanged) |
Filing History |
| 2023-01-20 5:17 pm Purchase |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
4,479,421 12.600% |
758,184 (+20.37%) |
Filing History |
| 2022-07-08 4:56 pm Purchase |
2022-06-30 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
3,721,237 10.500% |
3,721,237 (New Position) |
Filing History |
| 2022-05-11 5:14 pm Sale |
2022-05-09 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 2,154,058 6.100% |
-988,000 (-31.44%) |
Filing History |
| 2022-05-02 5:02 pm Purchase |
2022-04-22 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 1,929,201 5.400% |
1,929,201 (New Position) |
Filing History |
| 2022-03-18 9:00 pm Sale |
2022-03-17 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 3,142,058 8.900% |
-575,201 (-15.47%) |
Filing History |
| 2022-02-14 08:41 am Sale |
2021-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW Investments, LP | 2,353,015 6.700% |
-409,776 (-14.83%) |
Filing History |
| 2022-02-10 12:09 pm Sale |
2021-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
JANUS HENDERSON GROUP PLC JHG |
3,533 0.000% |
-1,984,597 (-99.82%) |
Filing History |
| 2022-01-05 9:26 pm Sale |
2022-01-03 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 3,717,259 10.540% |
-627,757 (-14.45%) |
Filing History |
| 2021-12-09 8:23 pm Sale |
2021-12-06 | 13D | iTeos Therapeutics, Inc. ITOS |
MPM BioVentures 2014, L.P. | 4,730,197 13.400% |
-407,017 (-7.92%) |
Filing History |
| 2021-10-19 4:06 pm Sale |
2021-10-13 | 13D | iTeos Therapeutics, Inc. ITOS |
MPM BioVentures 2014, L.P. | 5,137,214 14.600% |
-438,998 (-7.87%) |
Filing History |
| 2021-09-21 4:32 pm Sale |
2021-09-16 | 13D | iTeos Therapeutics, Inc. ITOS |
MPM BioVentures 2014, L.P. | 5,576,212 13.000% |
-486,008 (-8.02%) |
Filing History |
| 2021-02-12 3:39 pm Purchase |
2020-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
JANUS HENDERSON GROUP PLC JHG |
1,988,130 5.700% |
1,988,130 (New Position) |
Filing History |
| 2021-02-04 12:36 pm Purchase |
2021-01-25 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW Investments, LP | 2,762,791 7.880% |
2,762,791 (New Position) |
Filing History |
| 2020-08-07 5:42 pm Purchase |
2020-07-28 | 13D | iTeos Therapeutics, Inc. ITOS |
MPM BioVentures 2014, L.P. | 6,062,220 18.100% |
6,062,220 (New Position) |
Filing History |
| 2020-08-07 5:15 pm Purchase |
2020-07-28 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 4,345,016 13.000% |
4,345,016 (New Position) |
Filing History |
| 2020-08-05 4:30 pm Purchase |
2009-02-28 | 13D | iTeos Therapeutics, Inc. ITOS |
RA Capital Management, L.P. | 4,417,259 13.200% |
4,417,259 (New Position) |
Filing History |